| |
| |
|
| Insider
Information: |
Mario Ernest |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
1,089,697 |
|
|
Indirect Shares
|
264,473 |
|
|
| Direct
Value |
$8,309,557 |
|
|
|
Indirect Value
|
$120,004 |
|
|
| Total
Shares |
1,354,170 |
|
|
| Total
Value |
$8,429,560 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -41.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
Director |
2024-01-08 |
124,566 |
2024-01-08 |
20,752 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
372 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 13 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2016-05-12 |
4 |
B |
$2.30 |
$71,356 |
D/D |
31,042 |
380,724 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2009-12-17 |
4 |
OE |
$13.58 |
$458,240 |
D/D |
32,000 |
160,434 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2012-08-06 |
4 |
B |
$5.29 |
$169,280 |
D/D |
32,000 |
479,304 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2011-03-14 |
4 |
A |
$0.00 |
$0 |
I/I |
32,916 |
308,569 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2011-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
32,916 |
208,204 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2007-05-22 |
4 |
S |
$35.20 |
$1,204,434 |
I/I |
(34,120) |
0 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2019-07-11 |
4 |
B |
$2.78 |
$99,999 |
D/D |
35,971 |
272,741 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2010-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
37,962 |
187,159 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2010-03-10 |
4 |
A |
$0.00 |
$0 |
I/I |
37,962 |
263,153 |
0 |
- |
|
| CELG |
Celgene Corp |
Director |
– • – |
2015-12-28 |
4 |
S |
$119.36 |
$4,774,400 |
D/D |
(40,000) |
82,449 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2021-01-15 |
4 |
OE |
$2.27 |
$93,560 |
D/D |
41,216 |
375,743 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2003-09-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
41,666 |
64,721 |
|
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2016-05-19 |
4/A |
B |
$1.18 |
$50,875 |
D/D |
43,169 |
1,683,000 |
3.92 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2016-05-19 |
4 |
B |
$1.18 |
$50,875 |
D/D |
43,169 |
1,863,000 |
2.39 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Director |
– • – |
2018-10-29 |
4 |
OE |
$1.37 |
$152,941 |
D/D |
44,833 |
169,000 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2007-05-17 |
4 |
S |
$34.43 |
$1,572,410 |
I/I |
(45,552) |
200,000 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2013-08-14 |
4 |
B |
$0.00 |
$0 |
D/D |
47,059 |
119,713 |
2.31 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2014-11-18 |
4 |
A |
$0.00 |
$0 |
D/D |
48,885 |
48,885 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
– • – |
2006-05-10 |
4 |
B |
$21.30 |
$1,067,377 |
I/I |
50,000 |
50,000 |
2.1 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
– • – |
2009-05-06 |
4 |
B |
$8.49 |
$424,650 |
D/D |
50,000 |
71,004 |
2.39 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
– • – |
2011-02-07 |
4 |
B |
$6.94 |
$346,990 |
D/D |
50,000 |
131,004 |
2.39 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2015-05-18 |
4 |
S |
$18.09 |
$904,630 |
D/D |
(50,000) |
211,032 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2015-08-11 |
4 |
B |
$1.77 |
$88,500 |
D/D |
50,000 |
1,317,520 |
3.92 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2015-11-18 |
4 |
B |
$1.77 |
$88,500 |
D/D |
50,000 |
1,639,831 |
3.92 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2016-06-08 |
4 |
B |
$1.24 |
$62,000 |
D/D |
50,000 |
1,918,637 |
3.92 |
- |
|
372 Records found
|
|
Page 13 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
